|
|
Post by joeypotsandpans on Jun 20, 2021 13:17:00 GMT -5
There are reasons more than one member of this board interpret or question that posters motives. I agree the response was to Oldfish's medicare post regarding a possibility of increased scripts, but it's the nature of the tone of the response along with the successive posts after the initial response (3 consecutive posts within 25 minutes which could have easily been edited into the first of the three posts on 6/17). It just comes across at a time when some very positive FDA news was announced regarding UTHR's submission on Tyvaso (getting back on track here). I mentioned the term "paid troll" in a myriad of possibilities as I have no clue what their true motive is, but since you state with certainty they are not I guess you know them personally as you sound 100% certain of that as well that you're 100% certain they were a former MNKD sales rep. Granted it seems circumstantial enough that they were, however, this jury member has no factual evidence other than hear say and I assume nothing regarding same on a message board. I've stated previously directly to the individual that they seemed angry or bitter and suggested it seems like a cancer eating away at them to continue 2-3yrs. later of "trying to get their point across" and to just let it "the cancer" go. I would make that same suggestion to any long term disgruntled shareholder as well. Having said all that, doesn't it suck when your biological time clock is fixed so that you're awake on a Sunday morning at 4:30a Pacific time, especially on Father's Day 🤣😉. Happy Father's Day to all the pops out there!! awesomo stated: "Pguerrero broke news of Kendall’s and other c suite executive’s departures long before they were confirmed by MannKind or anyone else. Of course, that was met with the same vitriol on the message board of being a paid basher, disgruntled employee, troll, etc. So yeah, there is credibility there." Joey's take on it: Credibility? Hmm, lets take a look at what I see  PGuerrero's quote: "For the record, my closest fellow MNKD rep/confidant who taught me more about diabetes than spending 6 yrs with novo nordisk and praises Afrezza to this day (of course she left because as I have said nothing is sustainable selling Afrezza) still went to the ER twice in 2 yrs with dangerous lows. Still loves Afrezza and is taking it after leaving. So the “less hospitalizations” theory probably doesn’t work either. More real world feedback."
So in their own words: was with NOVO for 6 yrs. and didn't know as much about diabetes until they were with MNKD and the " fellow MNKD rep/confidant" who helped teach them more than NOVO ever did? WTF? Now you have someone that was with NOVO for six years and left that large stable company on their own accord? (truthfully we don't know the reason if voluntary or involuntary) to join a company with an unproven product that endo's don't want to or don't know how to sell? Hey how about this possibility, NOVO sent them over to MNKD to sabotage selling the greatest mealtime insulin in the world? Point being nothing is really known so you cannot vouch for someone's credibility other than your own personal opinion. Also, it is your opinion to use the word vitriol (cruel and bitter criticism) which I think is a bit extreme rather than just accepting others giving their opinions/assessment of one's credibility. I think it would be naive to believe that the short interest over the years has been held by retail investors/traders as opposed to largely by an entity whether it be a hedge fund, institution, etc., if you've been in this "game" as long as I have, as I stated previously, anything is possible, nothing surprises me ie., (GME, AMC, Hertz, Kodak, etc.) and trust no one. I'm not being cruel, I'm just going with the old adage: believe half of what you see and none of what you hear. One other aside, the insinuation that 2 trips to the ER for their confidant "disproves the less hospitalizations theory" is just another absurd statement as we don't know what the circumstances were behind those instances nor is 2 trips to an ER over 2 yrs. a sample size I would even begin to consider to make a claim like that. This will be my last post/response in this thread regarding this subject, if someone wants to carry on about it feel free to start a "pguerrero ex-rep?" thread |
|
|
|
Post by joeypotsandpans on Jun 20, 2021 7:32:26 GMT -5
UTHR Tyvaso Approval This is the thread topic, the real question should be why was this poster posting the above in this thread? Cretin can you answer this for me? This is the reason some "rational" posters are skeptical of this poster's motives (angry/bitter former employee, paid troll?, cares about my investments or trades?) 🤷♂️ who knows but when derailing an off Afrezza topic like this thread it has to make one wonder, is it because previous posts stopped getting attention? Yes, I can try to answer: it’s because he was directly responding to another poster who brought up the subject. So if you want to quibble about posters not staying on topic (a legit quibble, but unfortunately it happens pretty often), it seems your ire is misdirected in this instance. And no, pguererro is not a “paid troll” as you suggest. In fact, he’s one of the few posters on this board who has actually sold a MannKind product. Interesting that so many here want to ostracize him. There are reasons more than one member of this board interpret or question that posters motives. I agree the response was to Oldfish's medicare post regarding a possibility of increased scripts, but it's the nature of the tone of the response along with the successive posts after the initial response (3 consecutive posts within 25 minutes which could have easily been edited into the first of the three posts on 6/17). It just comes across at a time when some very positive FDA news was announced regarding UTHR's submission on Tyvaso (getting back on track here). I mentioned the term "paid troll" in a myriad of possibilities as I have no clue what their true motive is, but since you state with certainty they are not I guess you know them personally as you sound 100% certain of that as well that you're 100% certain they were a former MNKD sales rep. Granted it seems circumstantial enough that they were, however, this jury member has no factual evidence other than hear say and I assume nothing regarding same on a message board. I've stated previously directly to the individual that they seemed angry or bitter and suggested it seems like a cancer eating away at them to continue 2-3yrs. later of "trying to get their point across" and to just let it "the cancer" go. I would make that same suggestion to any long term disgruntled shareholder as well. Having said all that, doesn't it suck when your biological time clock is fixed so that you're awake on a Sunday morning at 4:30a Pacific time, especially on Father's Day 🤣😉. Happy Father's Day to all the pops out there!! |
|
|
|
Post by joeypotsandpans on Jun 19, 2021 16:44:25 GMT -5
Very good food for thought Joey, I don’t think it’s applicable in this one situation but that’s just my opinion, we all have people we trust and people we don’t and you’re the one actually taking the drug. I trust you. Also who in their right mind would short the stock right now…obviously there are people doing it but they’re gonna have to get out:-) Run up to FDA approval….. it’s not about Afrezza right now.That was my point Sports, this thread isn't about Afrezza so found it curious that the poster decided to instigate that "Afrezza failed scripts" thesis/opinion in this particular distinct thread. This thread is on topic for what will continue to lay the groundwork for MNKD to be a very successful company via Technosphere and its innovative technology and protected patents. The second drug approval is instrumental in continuing to validate the potential of what seems inevitable to come, that is the company's success |
|
|
|
Post by joeypotsandpans on Jun 19, 2021 13:02:08 GMT -5
Positive news for MannKind this week. Afrezza scripts jumping 2-3X next year not gonna happen. The leveling off is Real and it’s not because of coverage. See my prior comments 2-3 yrs ago about pricing differences in mealtime insulin. It’s too late for MannKind to drop the price of Afrezza 80% to still only be 3X the cost. The sales force expenditure is nothing but a money drain at this point for MK. Zero growth in 2 yrs. The Afrezza sales force is at least 30Million a year and that’s probably light. Volume would stay the same if the sales force was gone tomorrow. However MC, Medtronic dude, HR guy Stu (making $500k per year) and MB couldn’t justify their jobs. Had to comment cause I heard another person talk about 2 to 3 times growth w/Afrezza next year. UTHR Tyvaso Approval This is the thread topic, the real question should be why was this poster posting the above in this thread? Cretin can you answer this for me? This is the reason some "rational" posters are skeptical of this poster's motives (angry/bitter former employee, paid troll?, cares about my investments or trades?) 🤷♂️ who knows but when derailing an off Afrezza topic like this thread it has to make one wonder, is it because previous posts stopped getting attention? Just putting some food for thought as to why THIS thread which has a positive future outlook for the company? Last I looked there is still a fair amount of short interest that has to be dealt with. I trust no one but that's me, that's why I do my own due diligence. My endo has given me perspective from his professional view which I respect a ton more than some poster on a message board, just saying 😉 |
|
|
|
Post by joeypotsandpans on Jun 16, 2021 13:54:42 GMT -5
I believe MTOI was ahead of his time when he was recommending buying with two fists under $1 but that's just Joey's take on it 😉
|
|
|
|
Post by joeypotsandpans on Jun 16, 2021 12:17:42 GMT -5
MNKD Volume at the half day of trade, real time, 3,638,683 summary, 6,442,170 4.3050+0.2050 (+5.00%) As of 12:45PM EDT. Market open. This on a day where IBB/XBI is a half percent lower...thus the definition of relative strength. 😉 |
|
|
|
Post by joeypotsandpans on Jun 16, 2021 7:21:58 GMT -5
UTHR just announced FDA acceptance of Tyvaso DPI for review thank you mcbone. now that I am thinking about it, we have a gapper. Let's see where price opens, if the gap holds, the projection is price will go the same as the gap. said differently, a .50 (cent) gap holds, price targets, another 50 cents, = 1 dollar. let's see. Never mind MNKD now trading, $5.10. a dollar gap already. we are going to test top. the $6.54 one. 4.76 +0.66 (16.10%) Pre-Market: 06:18AM EDT Pre-Market Volume 43,796 and now, 4.52 +0.42 (10.24%) Pre-Market: and now, 4.65 +0.55 (13.41%) Pre-Market: joeypotsandpansOutside candle (lower low, higher high) on the monthly, overbought condition on monthly also relieved as RSI came in nicely from over 80, looks like we could end June with the potential for a resumption of the monthly uptrend after having had the positive MA crossover back in Feb., as you would say month not over but volume is on pace to exceed last month's volume. Monthly = long term = continues pointing "north" IMO 😉👍🏻 |
|
|
|
Post by joeypotsandpans on Jun 4, 2021 12:56:52 GMT -5
I’ve got a protective by order in at 3.25 so that it will not go that low. 😎 Thanks for the tipoff Boca, I just put mine in @ 3.26, I'm pulling a price is right strategy on you lol 🤪🤣😎😎 |
|
|
|
Post by joeypotsandpans on Jun 4, 2021 11:55:57 GMT -5
Peppy, where is the next level of support? Where do your charts tell you we are headed to? $3.30 is the 200 day. $3.14 and $3.12 this last delusion low.  This ☝️☝️☝️ (test of 200d) feels inevitable, whether it's 3.30,3.35,3.40 in the next week or so...should pass the test with inhalable colors IMO.😉 |
|
|
|
Post by joeypotsandpans on Jun 2, 2021 10:23:57 GMT -5
Since bad news for UTHR leads to a larger percentage drop in MNKD than in UTHR, it is pretty clear that everyone has given up on Afrezza ever being a money making drug. (Even though most agree that Afrezza is a great insulin option for some people.) Uvula, I have not given up as you alluded to in your prior post in the scripts thread, rather quite the contrary. You misinterpreted what I posted as I was saying that MNKD was not as dependent on Afrezza as it once was. My emphasis was on the value of Afrezza validating technosphere as a progressive way of treating future diseases. I never said that Afrezza would never be profitable, that was YOUR "twist" on my post. Regarding the difference in percentage loss between UTHR and MNKD sp, UTHR has a vastly different valuation and price multiple vs. earnings than MNKD so it's like comparing apples and oranges IMO. I respectfully disagree with the generalization that "everyone" has given up on Afrezza ever being a money making drug. 😉 |
|
|
|
Post by joeypotsandpans on May 28, 2021 12:32:09 GMT -5
Forget the bogie, the break and close over that trendline on volume is a birdie |
|
|
|
Post by joeypotsandpans on May 18, 2021 9:25:09 GMT -5
Peppy. Not to offend but I could look at your charts all day long and the only thing I could get out of them is a headache. Ahhhh. I do put my whole heart into it, trying to point out what I see with circles and arrows. price seems to be going up on low volume at the moment. MNKD has started to follow the IBB. ? Not sure of what purpose or why that poster would make that statement as no one has to tap any thread if it gives them a headache 🤷♂️...btw, I find it also follows the XBI 😉 |
|
|
|
Post by joeypotsandpans on May 14, 2021 10:52:32 GMT -5
Having a large player now follow us doesn't hurt. A good friend of mine is the top wealth manager at RBC, he can't buy anything for his clients unless the firm covers it. He was surprised they started coverage 😁 💎💎💎💎💎...I've raised it to a 5 diamond rating now 😉👍🏻
|
|
|
|
Post by joeypotsandpans on May 11, 2021 12:52:41 GMT -5
Hey Pep, Looks like you will be "fine" today  if not .22.. you should be pretty fine!!! I see diamonds. joeypotsandpans celo . ALL?  geomean pipe up.  🙄💎💎💎😁 |
|
|
|
Post by joeypotsandpans on May 9, 2021 11:37:25 GMT -5
Happy Mother Day to all of the Mannnkind Corporation Message shareholders; I am a Mannkind stock bag holder. I began my first and only stock purchased on May 1, 2015. by a splitting of $100,000 into $50,000 of shares of Mannkind and AMD. My AMD purchased price was $2.30 (which is $80ish). I got no answer yet from the question which I sent to Mannkind management. Here was it. "I sent the question to Michael asking when, whether or how, he will be able to have his confidence, competent or capable of recovering my $50,000 investment of $5.20 par shares on May 1, 2015. I got no answer yet. Maybe he is too busy or shams to answer it. I wish they have an excellent Mother Day party too, or they can sleep day by day, all day long as usual. 😊  You bought two companies that were going up against the "establishment", so far AMD has evolved into a huge winner vs. Intel, MNKD evolving on a slower pace but don't give up on her just yet 😉👍🏻 Happy Mother's Day to all those who are the backbone and strength behind their respective family's 😍🤩 |
|
if not .22.. you should be pretty fine!!! 
